179 related articles for article (PubMed ID: 7004341)
1. Klebsiella neonatal injections: mechanism of broadening aminoglycoside resistance.
Hardy DJ; Legeai RJ; O'Callaghan RJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):542-8. PubMed ID: 7004341
[TBL] [Abstract][Full Text] [Related]
2. Analysis of increasing antibiotic resistance of Klebsiella pneumoniae relative to changes in chemotherapy.
O'Callaghan RJ; Rousset KM; Harkess NK; Murray ML; Lewis AC; Williams WL
J Infect Dis; 1978 Sep; 138(3):293-8. PubMed ID: 359724
[TBL] [Abstract][Full Text] [Related]
3. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
Murray BE; Moellering RC
Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
[TBL] [Abstract][Full Text] [Related]
4. Plasmid-specified aminoglycoside-modifying enzymes in clinical isolates of Klebsiella pneumoniae.
Facinelli B; Montanari MP; Calegari L
Eur J Epidemiol; 1985 Mar; 1(1):48-53. PubMed ID: 3021514
[TBL] [Abstract][Full Text] [Related]
5. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
Knothe H; Kettner M; Kopsová D; Krcméry V
Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
[TBL] [Abstract][Full Text] [Related]
6. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
Reynolds AV; Hamilton-Miller JM; Brumfitt W
Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
[TBL] [Abstract][Full Text] [Related]
7. Incompatibility group K plasmids in bacteria isolated from a urinary tract infection.
Araki Y; Inoue M; Mitsuhashi S
Microbiol Immunol; 1983; 27(1):1-5. PubMed ID: 6346022
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
Reyonolds AV; Hamilton-Miller JM; Brumfitt W
J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside-modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola): explanation for high-level aminoglycoside resistance.
Murray BE; Moellering RC
Antimicrob Agents Chemother; 1979 Feb; 15(2):190-9. PubMed ID: 426512
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
McNeill WF; John JF; Twitty JA
Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
[TBL] [Abstract][Full Text] [Related]
12. Stability of aminoglycoside resistance in vitro in gentamicin-resistant Staphylococcus aureus.
Dixson S; Brumfitt W; Hamilton-Miller JM
J Hyg (Lond); 1984 Aug; 93(1):43-9. PubMed ID: 6747285
[TBL] [Abstract][Full Text] [Related]
13. A hospital epidemic caused by a multiple antibiotic resistant Klebsiella pneumoniae: implication of a conjugative R plasmid.
Facinelli B; Calegari L
Boll Ist Sieroter Milan; 1984 May; 63(2):111-7. PubMed ID: 6380523
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
Schmid B; Kayser FH
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
Traub WH; Fukushima PI
Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
18. Aminoglycoside resistance: a worldwide perspective.
Young LS; Hindler J
Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
[TBL] [Abstract][Full Text] [Related]
19. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
Jacoby GA; Blaser MJ; Santanam P; Hächler H; Kayser FH; Hare RS; Miller GH
Antimicrob Agents Chemother; 1990 Dec; 34(12):2381-6. PubMed ID: 1965106
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
